Home
Tags
Cancer Detection

Cancer Detection

Researchers are now targeting clonal hematopoiesis and building new solutions to help make liquid biopsy a frontline defense in the fight against cancer.

Beyond the Blood Draw: Making Liquid Biopsy More Accurate, One Mutation at a Time

Matthew Oberley, MD, PhD

As liquid biopsy becomes a standard tool in oncology, distinguishing tumor signals from clonal hematopoiesis is essential for accurate results

These lab-grown models replicate the environment inside the human body and could unlock clues about how cancer begins.

OHSU Researchers Identify New Tools for Early Cancer Detection, Treatment

Oregon Health & Science University

Scientific review discusses how new advances in 3D bioprinting, organoids, organs-on-a-chip aid in the fight against cancer

The new designation adds to growing evidence of the value of the Haystack MRD test for both clinical and pharmaceutical applications.

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Quest Diagnostics

Could this new test change how early-stage colorectal cancer is treated and improve patient outcomes?

CanScan is a noninvasive blood test powered by AI-driven whole-genome sequencing.

Blood-Based Multi-Cancer Detection Test Shows High Accuracy in Nature Medicine Study

Geneseeq

Geneseeq’s CanScan® test demonstrated 93 percent early-stage detection and a 98 percent specificity rate in a 3,700-person cohort

With these rising rates, early-onset colorectal cancer has become the leading cause of cancer-related death for men under 50 and the second-leading cause for women under 50 in the United States.

What’s Behind the Enormous Increase in Early-Onset Gastrointestinal Cancers?

Oxford University Press

The incidence of early-onset colorectal cancer is increasing globally, particularly in high-income countries

Photo of a young female cancer patient with long black hair in a health care setting shaking the hand of a healthcare provider conducting cancer screening.

2025’s Cancer Dilemma: Finding Tests That Diagnose Cancer at the Right Time

Arnon Chait, PhD, MBA

As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes

The Covaris truCOVER WGS PCR-free Library Prep Kit enhances the efficiency and quality of library preparation for whole genome sequencing of multiple sample types.

Emerging Technologies Guide: April 2025

Today's Clinical Lab

Recent new and emerging technologies in the field of laboratory medicine from the 2025 April Cancer & Precision Medicine issue of Today's Clinical Lab

Further AI adoption in clinical labs in 2025 could lead to better care for cancer patients.

Why Greater AI Adoption in Clinical Labs Will Occur in 2025

Razik Yousfi

Integration of platforms and responsible use of AI will become trends to watch

Illustration of the double helix structure of circulating tumor DNA against a blue background.

Tumor DNA in the Blood Can Predict Lung Cancer Outcome

The Francis Crick Institute

Researchers have found that a test to detect circulating tumor DNA can predict lung cancer outcome

Photo of a female clinician researcher sitting at multiple computer screens while examining physiological data from patients’ breath chemistry.

Detecting Evidence of Lung Cancer in Exhaled Breath

American Chemical Society

Researchers have determined that declines in one particular exhaled chemical can indicate the presence of lung cancer